RemeGen. 

$8.58
3
-$1.38-13.83%Wednesday 12:04

Statistics

Day High
10.93
Day Low
10.73
52W High
12.85
52W Low
9.54
Volume
400
Avg. Volume
47
Mkt Cap
5.62B
P/E Ratio
63.42
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Oct 29Expected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q3 2026
-0.08
0
0.08
0.16
Expected EPS
N/A
Actual EPS
0.1608444

Financials

12.91%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
527.81MRevenue
68.17MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease, rheumatoid arthritis, and myasthenia gravis; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of gastric cancer, urothelial carcinoma, breast cancer, and other tumors. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF); RC88, an antibody-drug conjugate (ADC) that targets mesothelin; and RC148, a bispecific antibody ADC drug that in Phase1/2 clinical studies targeting program cell death protein 1 (PD-1) and VEGF; RC278, an ADC drug for the treatment of multiple solid tumors; and RC288, a dual-antibody ADC drug for the treatment of various tumors. The company was founded in 2008 and is headquartered in Yantai, the People's Republic of China.
Show More
CEO
Jian Min Fang
Employees
3048
Country
China
ISIN
CNE1000048G6
WKN
000A2QGM4

Listings

0 Comments

Share your thoughts

FAQs

What is RemeGen. stock price today?▼
The current price of REGMF is $8.58 USD — it has decreased by -13.83% in the past 24 hours. Watch RemeGen. stock price performance more closely on the chart.
What is RemeGen. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange RemeGen. stocks are traded under the ticker REGMF.
Is RemeGen. stock price growing?▼
REGMF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year RemeGen. has showed a -9.45% decrease.
What is RemeGen. market cap?▼
Today RemeGen. has the market capitalization of 5.62B
When is the next RemeGen. earnings date?▼
RemeGen. is going to release the next earnings report on March 31, 2027.
What were RemeGen. earnings last quarter?▼
REGMF earnings for the last quarter are 0.16 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is RemeGen. revenue for the last year?▼
RemeGen. revenue for the last year amounts to 527.81M USD.
What is RemeGen. net income for the last year?▼
REGMF net income for the last year is 68.17M USD.
How many employees does RemeGen. have?▼
As of November 14, 2026, the company has 3,048 employees.
In which sector is RemeGen. located?▼
RemeGen. operates in the Health & Wellness sector.
When did RemeGen. complete a stock split?▼
RemeGen. has not had any recent stock splits.
Where is RemeGen. headquartered?▼
RemeGen. is headquartered in Yantai, China.